Mathematical analysis of HIV-1 dynamics in vivo

AS Perelson, PW Nelson - SIAM review, 1999 - SIAM
Mathematical models have proven valuable in understanding the dynamics of HIV-1
infection in vivo. By comparing these models to data obtained from patients undergoing …

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

CB Jabara, CD Jones, J Roach… - Proceedings of the …, 2011 - National Acad Sciences
Viruses can create complex genetic populations within a host, and deep sequencing
technologies allow extensive sampling of these populations. Limitations of these …

Fitness of drug resistant HIV-1: methodology and clinical implications

ME Quiñones-Mateu, EJ Arts - Drug Resistance Updates, 2002 - Elsevier
Recent studies of human immunodeficiency virus type 1 (HIV-1) fitness have examined the
potential relationship with plasma viral load, drug resistance, and disease progression. For …

Virus fitness: concept, quantification, and application to HIV population dynamics

ME Quinones-Mateu, EJ Arts - Quasispecies: Concept and Implications for …, 2006 - Springer
Viral fitness has been broadly studied during the past three decades, mainly to test
evolutionary models and population theories difficult to analyze and interpret with more …

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy

S Grabar, VL Moing, C Goujard, C Leport… - Annals of internal …, 2000 - acpjournals.org
Background: The prognostic value of discordant immunologic (CD4 cell increase) and
virologic (plasma HIV RNA level decrease) responses to antiretroviral treatment is not …

Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy

M Nijhuis, R Schuurman, D De Jong, J Erickson… - Aids, 1999 - journals.lww.com
Objective: It is thought as a consequence of continuous replication, HIV-1 has acquired an
optimal fitness state and that suboptimal antiretroviral therapy selects for drug resistant …

HIV-1 drug resistance in newly infected individuals

D Boden, A Hurley, L Zhang, Y Cao, Y Guo, E Jones… - Jama, 1999 - jamanetwork.com
ContextThere is concern that the widespread use of antiretroviral drugs to treat human
immunodeficiency virus 1 (HIV-1) infection may result in the increased transmission of drug …

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1

J Martinez-Picado, AV Savara, L Sutton… - Journal of …, 1999 - Am Soc Microbiol
The relative replicative fitness of human immunodeficiency virus type 1 (HIV-1) mutants
selected by different protease inhibitors (PIs) in vivo was determined. Each mutant was …

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy

PR Harrigana, M Whaley, JSG Montaner - Aids, 1999 - journals.lww.com
Objective: To determine the rate of plasma HIV-1 RNA rebound in patients stopping highly
active antiretroviral therapy (HAART) after achieving undetectable viral load. Design …

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy

S Sonza, HP Mutimer, R Oelrichs, D Jardine, K Harvey… - Aids, 2001 - journals.lww.com
Objective To determine whether HIV-1 can be recovered from blood monocytes as well as
resting, memory CD4 T lymphocytes of patients on highly active antiretroviral therapy …